Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer (LucaVax)
This study is not yet open for participant recruitment.
Verified April 2012
by Kael-GemVax Co., Ltd.
Study NCT01579188 Information provided by Kael-GemVax Co., Ltd.
First Received on April 13, 2012. Last Updated on April 18, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Carcinoma, Non-Small-Cell Lung
More general conditions related to this trial
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Interventions listed in this trial
Sponsors listed in this trial
Kael-GemVax Co., Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers